PlainRecalls
FDA Devices Moderate Class II Ongoing

BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533

Reported: December 6, 2023 Initiated: October 4, 2023 #Z-0400-2024

Product Description

BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533

Reason for Recall

Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.

Details

Units Affected
528,000
Distribution
US Nationwide distribution in the states of CA, NC, MI, WA, CO, FL, NJ, NM, IL, KY, TN, OH, TX, IN, LA, IA, MS, MO, NE, MD, NY, PA, GA, VA, ME, SC, RI, MA, PR.
Location
Sandy, UT

Frequently Asked Questions

What product was recalled?
BD Insyte Autoguard BC Shielded IV Catheter with Blood Control Technology 20GA X 1.00in, REF: 382533. Recalled by Becton Dickinson Infusion Therapy Systems Inc.. Units affected: 528,000.
Why was this product recalled?
Over-the-needle, intravascular catheters may have needles that do not retract properly into the barrel, which could result in contaminated needlestick injury, blood leaking from the insertion site or catheter, and repeat catheter insertion attempts, due to catheter being inadvertently removed from the insertion site.
Which agency issued this recall?
This recall was issued by the FDA Devices on December 6, 2023. Severity: Moderate. Recall number: Z-0400-2024.